Diabetes & Metabolism

Papers
(The TQCC of Diabetes & Metabolism is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)209
Metformin and COVID-19: From cellular mechanisms to reduced mortality132
Patients with diabetes are at higher risk for severe illness from COVID-19115
Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports107
Body mass index and outcome in patients with COVID-19: A dose–response meta-analysis98
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients85
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment83
Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials78
Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes68
Socioeconomic inequalities and type 2 diabetes complications: A systematic review67
Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes57
Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study55
Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms54
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-1954
A systematic review of nudge theories and strategies used to influence adult health behaviour and outcome in diabetes management54
Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: A retrospective study51
Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes46
Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes41
Elevated triglyceride–glucose index predicts risk of incident ischaemic stroke: The Rural Chinese cohort study40
Meat and fish intake and type 2 diabetes: Dose–response meta-analysis of prospective cohort studies39
Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the “Gordian Knot”?33
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies32
Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-1932
Smoking and diabetes interplay: A comprehensive review and joint statement32
Is the type 2 diabetes epidemic plateauing in France? A nationwide population-based study32
DPP-4 inhibition and COVID-19: From initial concerns to recent expectations31
Fulminant type 1 diabetes after COVID-19 vaccination29
Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-1927
Regulation of hepatokine gene expression in response to fasting and feeding: Influence of PPAR-α and insulin-dependent signalling in hepatocytes27
Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography26
Liraglutide and sitagliptin have no effect on intestinal microbiota composition: A 12-week randomized placebo-controlled trial in adults with type 2 diabetes25
Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trials25
Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction25
Diabetes mellitus in the era of climate change25
The obesity treatment dilemma: Why dieting is both the answer and the problem? A mechanistic overview24
Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease24
Diabetic ketoacidosis and mortality in COVID-19 infection23
Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD22
Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease22
The gut microbiota and diabetic cardiomyopathy in humans22
Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Dia22
Targeting ageing and preventing organ degeneration with metformin22
Triglyceride–glucose index associates with incident heart failure: A cohort study21
Practical implementation of automated closed-loop insulin delivery: A French position statement20
Exposure to persistent organic pollutants and the risk of type 2 diabetes: a case-cohort study20
The association between gestational diabetes mellitus and cancer in women: A systematic review and meta-analysis of observational studies20
Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL versus glargine 100 U/mL: A patient-level meta-analysis examining older and younger adults with type 2 diabetes20
Eye disorders other than diabetic retinopathy in patients with diabetes19
Lower limb amputations: protection with GLP-1 receptor agonists rather than increased risk with SGLT2 inhibitors?19
Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement18
SGLT2 inhibitors and the autonomic nervous system in diabetes: A promising challenge to better understand multiple target improvement18
COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes18
Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?18
Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes18
Cardiovascular risks of periodontitis and oral hygiene indicators in patients with diabetes mellitus18
The diuretic effects of SGLT2 inhibitors: A comprehensive review of their specificities and their role in renal protection17
Three alternative ways to screen for hyperglycaemia in pregnancy during the COVID-19 pandemic17
Gestational diabetes is associated with SARS-CoV-2 infection during pregnancy: A case-control study17
Serum uric acid in early pregnancy and risk of gestational diabetes mellitus: A cohort study of 85,609 pregnant women16
Associations of serum magnesium levels and calcium–magnesium ratios with mortality in patients with coronary artery disease16
SGLT2 inhibition during the COVID-19 epidemic: Friend or foe?16
Determinants of aspirin resistance in patients with type 2 diabetes16
Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors16
Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: Data from the MIRAD trial16
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study15
Euglycaemic ketoacidosis during gestational diabetes with concomitant COVID-19 infection15
Sodium–glucose cotransporter-2 inhibitors for diabetic kidney disease: Targeting Warburg effects in proximal tubular cells15
Lower trabecular bone score in type 2 diabetes mellitus: A role for fat mass and insulin resistance beyond hyperglycaemia15
Lean non-alcoholic fatty liver disease and risk of incident diabetes in a euglycaemic population undergoing health check-ups: A cohort study15
The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients15
Five-year mortality in patients with diabetic foot ulcer during 2009–2010 was lower than expected15
Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study14
Association of hyperglycaemia with hospital mortality in nondiabetic COVID-19 patients: A cohort study14
Insulin sensitivity improvement with exercise training is mediated by body weight loss in subjects with metabolic syndrome14
Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht Study14
Challenging 2019 ESC guidelines for the management of type 2 diabetes14
Performance of a selective screening strategy for diagnosis of hyperglycaemia in pregnancy as defined by IADPSG/WHO criteria14
Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy14
Association between sodium glucose co-transporter 2 inhibitors and incident glaucoma in patients with type 2 diabetes: A multi-institutional cohort study in Taiwan13
Antidiabetic agents and risk of atrial fibrillation/flutter: A comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists13
Protection by metformin against severe Covid-19: An in-depth mechanistic analysis13
Association of diabetes and outcomes in patients with COVID-19: Propensity score-matched analyses from a French retrospective cohort13
Fasting plasma glucose variability in midlife and risk of Parkinson's disease: A nationwide population-based study12
Canagliflozin could improve the levels of renal oxygenation in newly diagnosed type 2 diabetes patients with normal renal function12
Association between sleep duration in early pregnancy and risk of gestational diabetes mellitus: a prospective cohort study12
Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes12
A high lean body mass is not protecting from type 2 diabetes in the presence of a high body fat mass12
SGLT2 inhibition increases serum copeptin in young adults with type 1 diabetes12
Bidirectional relationship between diabetes and pulmonary function: a systematic review and meta-analysis12
Dietary sodium and potassium and risk of diabetes: A prospective study using data from the China Health and Nutrition Survey12
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes11
Prognosis associated with initial care of increased fasting glucose in early pregnancy: A retrospective study11
Glycaemic control for painful diabetic peripheral neuropathy is more than fasting plasma glucose and glycated haemoglobin11
Impact of gender on relative rates of cardiovascular events in patients with diabetes11
0.023777961730957